Our Medicines

To contact Medical Information about our products or report an adverse event, click here.

Focusing on the health of Canadians

Takeda’s top priority is the health of Canadians. Their well-being is central to our work and drives our commitment to deliver a diverse portfolio of innovative treatments.

Current important medicines available to Canadians from Takeda Canada include:

For legacy Shire product information, please visit
https://www.takeda.com/en-ca/what-we-do/our-medicines/shire-products

PRODUCTS
ADDERALL XR^® mixed salts amphetamine	Product Monograph
ADVATE^® Antihemophilic Factor (Recombinant)	Product Monograph
ADYNOVATE^® Antihemophilic Factor (Recombinant), PEGylated	Product Monograph
AGRYLIN^® anagrelide hydrochloride	Product Monograph
ALUNBRIG^® brigatinib	Product Monograph
ANTITHROMBIN III NF^® Antithrombin III (Human)	Product Monograph
CINRYZE^® C1 inhibitor [human]	Product Monograph
CUVITRU® Normal Immunoglobulin (Human)	Product Monograph
DEXILANT^® dexlansoprazole	Product Monograph
ELAPRASE^® idursulfase for injection	Product Monograph
ENTYVIO^® vedolizumab	Product Monograph
FEIBA^® NF Anti-Inhibitor Coagulant Complex	Product Monograph
FIRAZYR^® icatibant injection	Product Monograph
FOSRENOL^® lanthanum carbonate hydrate	Product Monograph
FRUZAQLA^TM fruquintinib	Product Monograph
GAMMAGARD LIQUID^® Immunoglobulin Intravenous (Human)	Product Monograph
GAMMAGARD^® S/D Immunoglobulin Intravenous (Human) [IGIV]	Product Monograph
GLASSIA^® Alpha-1 Proteinase Inhibitor (Human) Injection	Product Monograph
HyQvia^® Normal Immunoglobulin (Human) and Recombinant Human Hyaluronidase	Product Monograph
IMMUNINE^® VH Factor IX Concentrate (Human)	Product Monograph
INTUNIV XR^® guanfacine hydrochloride	Product Monograph
KAZANO^® alogliptin (as alogliptin benzoate) and metformin hydrochloride	Product Monograph
LIVTENCITY^® maribavir tablets	Product Monograph
MEZAVANT^® ^mesalamine	Product Monograph
NESINA^® alogliptin (as alogliptin benzoate)	Product Monograph
NINLARO^® ixazomib (as ixazomib citrate)	Product Monograph
OBIZUR^® Antihemophilic Factor (Recombinant), Porcine Sequence	Product Monograph
ONDISSOLVE^® ODF ondansetron	Product Monograph
PANTOLOC^® pantoprazole sodium	Product Monograph
REPLAGAL^® agalsidase alfa for injection	Product Monograph
REVESTIVE^® Teduglutide for injection	Product Monograph
RIXUBIS^® Recombinant Coagulation Factor IX (rFIX), Nonacog gamma for Injection	Product Monograph
TAKHZYRO^® lanadelumab injection	Product Monograph
TECTA^® pantoprazole magnesium	Product Monograph
VONVENDI^® Lyophilized Powder for Solution	Product Monograph
VPRIV^® velaglucerase alfa	Product Monograph
VYVANSE^® lisdexamfetamine dimesylate	Product Monograph

ADDERALL XR^® and ADDERALL^® are registered trademarks of Takeda Pharmaceuticals U.S.A., Inc.

ADYNOVATE^® is a registered trademark of Baxalta Incorporated.

ALUNBRIG^® and the ALUNBRIG Logo^® are registered trademarks of ARIAD Pharmaceuticals, Inc.

CINRYZE® and the CINRYZE Logo are registered trademarks of ViroPharma Biologics LLC, a Takeda company.

CUVITRU^® is a registered trademark of Baxalta Incorporated.

DEXILANT^® is a trademark of Takeda Pharmaceuticals U.S.A., Inc and used under licence by Takeda Canada Inc.

ELAPRASE^® and the ELAPRASE Logo^® are registered trademarks of Shire Human Genetic Therapies, Inc.

ENTYVIO^® is a registered trademark of Millennium Pharmaceuticals, Inc. and used under licence by Takeda Canada Inc.

FEIBA^® is a registered trademark of Baxalta Incorporated.

FIRAZYR^® and the FIRAZYR Logo are registered trademarks of Shire Orphan Therapies GmbH.

FOSRENOL® and the FOSRENOL Logo are registered trademarks of Shire International Licensing BV, a Takeda company.

FRUZAQLA^TM and the FRUZAQLA Logo are trademarks of HUTCHMED Group Enterprises Limited, used under license.

GAMMAGARD^® and GAMMAGARD LIQUID^® are registered trademarks of Baxalta Incorporated.

GLASSIA^® is a registered trademark used under license from Kamada Ltd.

HyQvia® is a registered trademark of Baxalta Incorporated.

IMMUNINE^® is a registered trademark of Baxalta Incorporated.

INTUNIV XR^® is a registered trademark of Takeda Pharmaceuticals U.S.A., Inc.

KAZANO^® is a registered trademark of Takeda Pharmaceutical Company Limited.

LIVTENCITY^® and the LIVTENCITY Logo^® are registered trademarks of Takeda Pharmaceuticals International AG.

MEZAVANT^® and the MEZAVANT Logo^® are registered trademarks of Nogra Pharma Limited, used under license.

NESINA^® is a registered trademark of Takeda Pharmaceutical Company Limited.

NINLARO^® is a registered trademark of Millennium Pharmaceuticals, Inc.

OBIZUR^® is a registered trademark of Baxalta Incorporated.

ONDISSOLVE^® is a registered trademark of Takeda GmbH.

PANTOLOC^® and TECTA^® are registered trademarks of Takeda GmbH. Used under licence.

REPLAGAL^® and the REPLAGAL Logo^® are registered trademarks of Shire Human Genetic Therapies, Inc.

REVESTIVE^® is a registered trademark of Shire-NPS Pharmaceuticals, Inc., a Takeda company.

RIXUBIS^® and BAXJECT^® II are registered trademarks of Baxalta Incorporated.

TAKHZYRO^® is a registered trademark of Dyax Corp.

ULORIC^® is a registered trademark of Teijin Limited and used under licence by Takeda Canada Inc.

VONVENDI^® is a registered trademark of Baxalta Incorporated.

VPRIV^® and the VPRIV Logo^® are registered trademarks of Shire Human Genetic Therapies, Inc.